SeaBridge Investment Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

SeaBridge Investment Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-100	Closed	-$3K	–	267
2017 Q2	$3K	Hold	100	–	–	﹤0.01%	254
2017 Q1	$3K	Hold	100	–	–	﹤0.01%	249
2016 Q4	$4K	Hold	100	–	–	﹤0.01%	240
2016 Q3	$5K	Hold	100	–	–	﹤0.01%	245
2016 Q2	$5K	Hold	100	–	–	﹤0.01%	253
2016 Q1	$5K	Hold	100	–	–	﹤0.01%	224
2015 Q4	$7K	Hold	100	–	–	﹤0.01%	212
2015 Q3	$6K	Hold	100	–	–	﹤0.01%	212
2015 Q2	$6K	Buy	+100	New	+$6.17K	﹤0.01%	208

Other funds holding TEVA

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

SeaBridge Investment Advisors's TEVA Position: Q3 2017 in Review

SeaBridge Investment Advisors sold out of Teva Pharmaceuticals (TEVA) in Q3 2017, closing a stake of 100 shares — an estimated $3K sold.

SeaBridge Investment Advisors first reported a position in TEVA in Q2 2015 and held it in 9 quarters. The position peaked at $7K in Q4 2015. 535 funds tracked by Wall St. Rank hold TEVA as of Q3 2017.

SeaBridge Investment Advisors reported no remaining Teva Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
SeaBridge Investment Advisors sold 100 Teva Pharmaceuticals shares in Q3 2017, an estimated $3K.
SeaBridge Investment Advisors first reported a position in Teva Pharmaceuticals in Q2 2015 and held it in 9 quarters.
SeaBridge Investment Advisors's Teva Pharmaceuticals position peaked at $7K in Q4 2015.
535 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2017.

Based on SeaBridge Investment Advisors's 13F filing for Q3 2017, filed 19 Oct 2017.